Brigita Smolović, MD, PhD, is an Professor of Internal Medicine at the University of Montenegro and a consultant gastroenterologist–hepatologist at the Clinical Center of Montenegro. She obtained her MD degree from the University of Belgrade and completed specialization in Internal Medicine, subspecialization in Gastroenterology and Hepatology, as well as her MSc and PhD degrees in the field of gastrointestinal diseases. Her clinical and research interests include inflammatory bowel disease, upper gastrointestinal bleeding, Helicobacter pylori infection, liver diseases, gastrointestinal oncology, and quality of life in patients on biological therapy. She is the principal investigator of the ENTranM study, a multicenter observational study evaluating vedolizumab effectiveness in biologic-naïve IBD patients in Montenegro. Professor Smolović has authored and co-authored numerous peer-reviewed publications in international journals (Eur J Gastroenterol Hepatol, Oncology, Liver International, J Diabetes Complications, Eur Rev Med Pharmacol Sci) and national clinical guidelines. She has actively participated in international congresses (ECCO, ESGE Days, WCOG, UEG) with oral and poster presentations, several of which received awards. She served as President of the Organizing Committee of the 1st International Congress of Gastroenterology and Hepatology of Montenegro (2023). She is a member of ESGE, EASL, UEG, WGO, and national professional societies.